ATE452644T1 - Kräuterextrakt aus sapindus trifoliatus, enthaltend eine mischung aus saponinen mit krampflösender wirkung - Google Patents

Kräuterextrakt aus sapindus trifoliatus, enthaltend eine mischung aus saponinen mit krampflösender wirkung

Info

Publication number
ATE452644T1
ATE452644T1 AT03791169T AT03791169T ATE452644T1 AT E452644 T1 ATE452644 T1 AT E452644T1 AT 03791169 T AT03791169 T AT 03791169T AT 03791169 T AT03791169 T AT 03791169T AT E452644 T1 ATE452644 T1 AT E452644T1
Authority
AT
Austria
Prior art keywords
site
glutamate
mixture
saponins
herbal extract
Prior art date
Application number
AT03791169T
Other languages
English (en)
Inventor
Sudershan Kumar Arora
Vandita Srivastava
Veeranjaneyulu Addepalli
Sridhar Natesan
Rajan Goel
Original Assignee
Lupin Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lupin Ltd filed Critical Lupin Ltd
Application granted granted Critical
Publication of ATE452644T1 publication Critical patent/ATE452644T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Otolaryngology (AREA)
  • Hospice & Palliative Care (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
AT03791169T 2002-08-28 2003-08-27 Kräuterextrakt aus sapindus trifoliatus, enthaltend eine mischung aus saponinen mit krampflösender wirkung ATE452644T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN779MU2002 2002-08-28
PCT/IN2003/000289 WO2004019960A2 (en) 2002-08-28 2003-08-27 Herbal extract comprising a mixture of saponins obtained from sapindus trifoliatus for anticonvulsant activity

Publications (1)

Publication Number Publication Date
ATE452644T1 true ATE452644T1 (de) 2010-01-15

Family

ID=31972132

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03791169T ATE452644T1 (de) 2002-08-28 2003-08-27 Kräuterextrakt aus sapindus trifoliatus, enthaltend eine mischung aus saponinen mit krampflösender wirkung

Country Status (10)

Country Link
US (1) US20050249831A1 (de)
EP (1) EP1556062B1 (de)
JP (1) JP2006501251A (de)
AT (1) ATE452644T1 (de)
AU (1) AU2003276686B2 (de)
CA (1) CA2497161A1 (de)
DE (1) DE60330698D1 (de)
NZ (1) NZ538518A (de)
WO (1) WO2004019960A2 (de)
ZA (1) ZA200502461B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100594027C (zh) * 2001-12-05 2010-03-17 张喜田 番木鳖碱、马钱子碱和一叶秋碱及其盐的透皮剂
US20080182801A1 (en) 2003-12-22 2008-07-31 Btg International Limited Core 2 glcnac-t inhibitors
GB0329667D0 (en) 2003-12-22 2004-01-28 King S College London Core 2 GlcNAc-T inhibitor
GB0513881D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors III
WO2006007741A1 (de) * 2004-07-16 2006-01-26 Thoeny Rolf Flüssigwaschmittel auf saponinbasis
GB0513888D0 (en) 2005-07-06 2005-08-10 Btg Int Ltd Core 2 GLCNAC-T Inhibitors II
DE102007006122A1 (de) * 2007-02-02 2008-08-07 Krewel Meuselbach Gmbh Cistusextrakte
EP2285821B1 (de) 2008-06-17 2014-12-17 Pawan Kumar Goel Neuartiges verfahren zur extraktion von furostanol-saponinen aus bockshornkleesamen
US20100316752A1 (en) * 2009-06-10 2010-12-16 Heng-Jui Hsu Method for extracing substances from soapberry fruit and seed and products made therefrom
WO2019182745A1 (en) * 2018-03-19 2019-09-26 Bryn Pharma, LLC Epinephrine spray formulations
CN110025623A (zh) * 2019-03-21 2019-07-19 李和伟 一种冻干制剂及其制备方法和应用
EP4316461A1 (de) * 2022-08-05 2024-02-07 BRAIN Biotech AG Konservierungszusammensetzung

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61267528A (ja) * 1984-11-26 1986-11-27 Yamanouchi Pharmaceut Co Ltd 吸収促進剤を含有するカルシトニン経鼻剤
JPH02262510A (ja) * 1987-08-11 1990-10-25 Inahata Koryo Kk 歯ミガキ組成物
MX9606493A (es) * 1994-06-24 1997-03-29 Nippon Shinyaku Co Ltd Derivado de triterpeno y composicion medicinal.
JPH09169648A (ja) * 1995-12-22 1997-06-30 Nippon Shinyaku Co Ltd 医薬組成物
JP2003535830A (ja) * 2000-05-25 2003-12-02 ルピン・リミテッド ムクロジおよびアマラキ抽出物を含む抗片頭痛用組み合わせ

Also Published As

Publication number Publication date
AU2003276686B2 (en) 2009-03-26
WO2004019960A3 (en) 2004-05-13
JP2006501251A (ja) 2006-01-12
EP1556062B1 (de) 2009-12-23
CA2497161A1 (en) 2004-03-11
AU2003276686A1 (en) 2004-03-19
WO2004019960A2 (en) 2004-03-11
NZ538518A (en) 2008-10-31
DE60330698D1 (de) 2010-02-04
US20050249831A1 (en) 2005-11-10
ZA200502461B (en) 2005-11-01
EP1556062A2 (de) 2005-07-27

Similar Documents

Publication Publication Date Title
ATE452644T1 (de) Kräuterextrakt aus sapindus trifoliatus, enthaltend eine mischung aus saponinen mit krampflösender wirkung
WO2003087094A3 (en) Pyrrolidinium derivatives as antagonists of m3 muscarinic receptors
HUP0301688A3 (en) Amino alcohol derivatives, process for their preparation and pharmaceutical compositions containing them
BR0108678A (pt) Novos compostos
HUP0301344A3 (en) Non-steroidal inflammation inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0103767A3 (en) Use of estrogen agonist/antagonist for preparation of pharmaceutical compositions available for treating osteoarthritis
NO331093B1 (no) Somatostatinanaloger, fremgangsmåte for fremstilling, farmasøytisk sammensetning og anvendelse derav.
NO982729L (no) Antagonister av det gonadotropinfrigj°rende hormon
HUP0300434A3 (en) Oxazole derivatives and their uses as tyrosine kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
HUP0203836A3 (en) 1,3-disubstituted pyrrololidines as alpha-2-adrenoceptor antagonists, process for their preparation and pharmaceutical compositions containing them and their use
GR20040100121A (el) Συνθεσεις περιεχουσες αγωνιστη υποδοχεων s1p
WO2006033700A3 (en) Her2 antibody composition
WO2003061584A3 (en) Novel substituted benzimidazole dosage forms and method of using same
ES2196063T3 (es) Utilizacion de agentes antagonistas competitivos de progesterona para la preparacion de medicamentos destinados al tratamiento de hemorragias uterinas disfuncionales.
MXPA01012882A (es) Composiciones y metodos que comprenden gluconato de morfina.
BR0114576A (pt) Composto, composição farmacêutica, uso de um composto, método de tratar um estado doentio e processo para preparar um composto
PL367094A1 (en) Pharmaceutical compositions, kits and methods comprising combinations of estrogen agonists/antagonists, estrogens and progestins
CA2360313A1 (en) Glucocorticoid receptor modulators
BR0214199A (pt) Composições de fenóxi amina para liberar agentes ativos, forma de unidade de dosagem e método de administração
GB9917822D0 (en) Nmda antagonist
WO2001001972A3 (en) SELECTIVE iGluR5 RECEPTOR ANTAGONISTS FOR THE TREATMENT OF MIGRAINE
EP1262196A3 (de) Kombination eines Inhibitoren der Monoaminwiederaufnahme und eines Opioidanatagonisten zur Verwendung in Alkoholismus und Alkoholsucht
BR9806754A (pt) Composições paroxetine.
BR0317623A (pt) Escitalopram, composição farmacêutica, e, uso de hidrobrometo de escitalopram
WO2004094400A3 (en) Substituted benzopyrans as selective estrogen receptor-beta agonists

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties